University of Michigan
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Michigan sits in the top decile of US sponsors by registered trial count (#19 of 15,742 sponsors by registered trial count).
University of Michigan: 1,327 sponsored US clinical trials, 179 recruiting.
University of Michigan sponsors 1,327 registered US clinical trials on ClinicalTrials.gov, 179 of them currently recruiting, and 971 completed. 94 of these trials are in Phase 3-4 (later-stage) and 159 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Depression, with 15 trials.
Top-decile sponsor footprint
University of Michigan ranks in the top decile of sponsors by registered trial count (#19 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
971 of 1,083 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (89.7%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,327 total, page 10 of 27
Effect of Chewing a Calcium Supplement Before Fluoride Rinse on Salivary Fluoride
NCT04620252
Improving Depression Via E-Health Access (IDEA) Study
NCT04689568
How do the Neck Muscles Influence Head Acceleration During Sport-associated Impact Events in High School Athletes?
NCT03883165
The BRAINFOOD Trial to Prevent Recurrent Hepatic Encephalopathy.
NCT04675775
Metformin as an Adjunctive Therapy to Catheter Ablation in Atrial Fibrillation
NCT04625946
Previously Implanted Pudendal Nerve Stimulation
NCT04473469
Non-Pharmaceutical Intervention for Cirrhotic Cramps Reduction: The NICCles Trial
NCT04650295
Targeting Normoxia in Neonates With Cyanotic Congenital Heart Disease in the Intra-operative and Immediate Post-operative Period
NCT04452188
Addressing Violence and HIV Care Among Transgender Women
NCT04813484
Utilizing CT Based Imaging Parameters of Body Composition to Understand Heterogeneity of Response to Biologic Therapies in Severe Asthma Cohorts
NCT06922760
Prevention Interventions for Opioid Misuse
NCT04550715
Psychological and Clinical Factors That Predict Intent to Deprescribe Medications Among Older Adults
NCT04676282
Pilot Testing a New Pregnancy Decision Making Tool for Women With Physical Disabilities
NCT04651114
STIM+: PET Biomarker Education & Disclosure
NCT04818255
Improving Outcomes for Care Partners of Persons With Traumatic Brain Injury
NCT04570930
Incidence and Predictors of Acute and Chronic Complications in Patients With Diabetes and Severe COVID-19
NCT05200819
MOMSonLINE2 ; A Pilot Study Testing Recruitment and Retention of Women of Color to an Online Support Group for Bereaved Mothers
NCT04600076
Effect of Peripheral Neuromodulation on Vaginal Blood Flow
NCT04384172
Mobile Technology and Data Analytics to Identify Real-time Predictors of Caregiver Well-Being
NCT04556591
Feasibility and Preliminary Effects of the Resilience-based, Energy Management to Enhance Wellbeing in Systemic Sclerosis (RENEW) Intervention
NCT04588714
Virtual AppLication-supported ENvironment To INcrease Exercise During Cardiac Rehabilitation Study
NCT04587882
WeCareAdvisor: A Web-Based Tool to Improve Quality of Life for Military Veterans With Dementia and Their Caregivers
NCT04587583
My MS Toolkit + Coaching: A Guided Web-based Symptom Self-Management Program for People With MS
NCT04552561
Brief Intervention Combined With Health Coaching Via Social Media for Cannabis Use
NCT04316741
Facilitating Use of the National Suicide Prevention Lifeline in Alcohol Patients (Reach Out)
NCT04488055
Light at Night Study
NCT04251234
C-myc Biomarker Study for Diabetic Foot Ulcers
NCT04591691
The Optimization of Medications in Chronic Heart Failure Using a Website
NCT04580004
Michigan Alcohol Improvement Network- Alcohol Reduction and Treatment Trial
NCT04473482
A Systems-Level Intervention for Rural Adults With Depression
NCT04502186
Pudendal Nerve Mapping Towards Improved Neuromodulation for Urinary Retention
NCT04236596
Recombinant Human Platelet-derived Growth Factor in Combination With Collagen Matrix
NCT04462237
Studying Students at Risk for COVID-19
NCT04766788
No Power Bionic Lower Extremity Prosthesis
NCT04070105
Psychosocial Pain Management to Improve Opioid Use Disorder Treatment Outcomes
NCT04433975
Effects of Low FODMAP Diet on Colonic Epithelial Physiology in Diarrhea-predominant Irritable Bowel Syndrome
NCT04542018
Screening and Intervention for Glaucoma and Eye Health Through Telemedicine
NCT04274764
Automated Quantitative Ulcer Analysis Study
NCT04420962
HealthyLifetime: Health Coaching for Older Adults
NCT05070923
Mechanistic Study of Ocrevus
NCT04459988
TEWL Biomarker Study for Diabetic Foot Ulcer Recurrence
NCT04558775
Ultrasound Crestal Bone Topography of Edentulous Ridges
NCT04487379
Comparing the Effects of Exercise on the Structure and Function of Fat Tissue
NCT05328570
Dipyridamole to Prevent Coronavirus Exacerbation of Respiratory Status (DICER) in COVID-19
NCT04391179
Project IntERact Study
NCT03940716
Positive Psychology for Chronic Pain Self-management
NCT04321239
Providing Mental Health Precision Treatment
NCT04342494
Effect of Academic Detailing to Reduce Opioid Prescribing in Dentistry
NCT04425668
Monitoring Health Care Workers at Risk for COVID-19 Using Wearable Sensors and Smartphone Technology
NCT04756869
Intern Health Study: 2020 Cohort Micro-Randomized Trial
NCT05106439
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 79 |
| Phase 2 | 80 |
| Phase 3 | 25 |
| Phase 4 | 69 |
Therapeutic Areas
What is open in the University of Michigan pipeline
179 recruiting of 1,327 indexed (13% open); 971 completed (73%).
Phase mix: 94 late (III/IV) vs 159 early (I/II) (early-phase heavy).
Top condition: Depression (15 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Michigan: open-pipeline peers nationwide
Peers matched on 1,327 registered trials and 13% open enrollment, not the therapeutic-area sidebar.
University of Michigan sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,327 trials (± recruiting share)
- Eli Lilly and Company · 1,341 trials · 9% recruiting
- GlaxoSmithKline · 1,345 trials · 4% recruiting
- AstraZeneca · 1,285 trials · 12% recruiting
- University of Colorado, Denver · 1,283 trials · 21% recruiting
Sponsors near 13% open enrollment (± trial volume)
- Wayne State University · 13% recruiting · 163 trials
- Case Comprehensive Cancer Center · 14% recruiting · 407 trials
- Albany Medical College · 13% recruiting · 52 trials
- Taiho Oncology · 13% recruiting · 52 trials
Related
What to do with this University of Michigan page
1,327 registered trials is a research-attention snapshot, not an endorsement of University of Michigan or any single study.
- 179 of University of Michigan's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Depression is the condition University of Michigan studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Depression trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of Michigan pipeline card: 1,327 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.